APA

Cao S., Abraham A., Nair M. G., Pati R., Galivan J. H., Hausheer F. H. & Rustum Y. M. (19990210). Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Cao S, Abraham A, Nair M G, Pati R, Galivan J H, Hausheer F H and Rustum Y M. 19990210. Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Cao S., Abraham A., Nair M. G., Pati R., Galivan J. H., Hausheer F. H. and Rustum Y. M. (19990210). Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Cao S, Abraham A, Nair M G, Pati R, Galivan J H, Hausheer F H and Rustum Y M. Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity. : Clinical cancer research : an official journal of the American Association for Cancer Research. 19990210.